Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial-Reference-Cited by-同舟云学术

Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial

Published:2019-02 Issue:2 Volume:4 Page:119-126
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Gupta Neil,Mbituyumuremyi Aimable,Kabahizi Jules,Ntaganda Fabien,Muvunyi Claude Mambo,Shumbusho Fabienne,Musabeyezu Emmanuel,Mukabatsinda Constance,Ntirenganya Cyprien,Van Nuil Jennifer Ilo,Kateera Fredrick,Camus Gregory,Damascene Makuza Jean,Nsanzimana Sabin,Mukherjee Joia,Grant Philip M

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

2. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis;Mokdad;BMC Med,2014

3. Global hepatitis report 2017,2017

4. Hepatitis C virus genotype 4: genotype 1's little brother;Llaneras;J Viral Hepat,2017

5. Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection;Abergel;Hepatology,2016

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study;The Lancet Microbe;2024-07

2. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

3. ‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment;Gut;2024-05-23

4. Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals;The Journal of Infectious Diseases;2024-05-08

5. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial);Scientific Reports;2024-05-03